A decade of research work has led to many medicinal innovations. These include a drug delivery platform for the treatment of peritoneal cancer, which resulted in the spin-off company NaDeNo. And today ...
AbbVie receives European marketing approval for Elahere for the treatment of platinum-resistant ovarian cancer: North Chicago, Illinois Tuesday, November 19, 2024, 10:00 Hrs [IST] ...